BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23681843)

  • 1. Putting the pieces together: necrolytic migratory erythema and the glucagonoma syndrome.
    Halvorson SA; Gilbert E; Hopkins RS; Liu H; Lopez C; Chu M; Martin M; Sheppard B
    J Gen Intern Med; 2013 Nov; 28(11):1525-9. PubMed ID: 23681843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Necrolytic migratory erythema as the first manifestation of pancreatic neuroendocrine tumor.
    Wu SL; Bai JG; Xu J; Ma QY; Wu Z
    World J Surg Oncol; 2014 Jul; 12():220. PubMed ID: 25029913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagonoma syndrome with severe erythematous rash: A rare case report.
    Wang ZX; Wang F; Zhao JG
    Medicine (Baltimore); 2019 Sep; 98(37):e17158. PubMed ID: 31517863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
    Tremblay C; Marcil I
    J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necrolytic migratory erythema and glucagonoma rising from pancreatic head.
    Tseng HC; Liu CT; Ho JC; Lin SH
    Pancreatology; 2013; 13(4):455-7. PubMed ID: 23890147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon cell adenomatosis: a new entity associated with necrolytic migratory erythema and glucagonoma syndrome.
    Otto AI; Marschalko M; Zalatnai A; Toth M; Kovacs J; Harsing J; Tulassay Z; Karpati S
    J Am Acad Dermatol; 2011 Aug; 65(2):458-459. PubMed ID: 21763589
    [No Abstract]   [Full Text] [Related]  

  • 7. Image Gallery: Necrolytic migratory erythema associated with glucagonoma.
    Aragón-Miguel R; Prieto-Barrios M; Calleja-Algarra A; Pinilla-Martin B; Rodriguez-Peralto J; Ortiz-Romero P; Rivera-Diaz R
    Br J Dermatol; 2019 Jan; 180(1):e1. PubMed ID: 30604550
    [No Abstract]   [Full Text] [Related]  

  • 8. Necrolytic migratory erythema associated with glucagonoma treated successfully with cyclosporine.
    Jiménez-Gallo D; Ossorio-García L; de la Varga-Martínez R; Arjona-Aguilera C; Linares-Barrios M
    Dermatol Ther; 2017 Jul; 30(4):. PubMed ID: 28508546
    [No Abstract]   [Full Text] [Related]  

  • 9. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome.
    Remes-Troche JM; García-de-Acevedo B; Zuñiga-Varga J; Avila-Funes A; Orozco-Topete R
    J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):591-5. PubMed ID: 15324403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Necrolytic migratory erythema in a patient with a glucagonoma].
    Demirbas M; Prens B
    Ned Tijdschr Geneeskd; 2021 Oct; 165():. PubMed ID: 34854628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema.
    Tolliver S; Graham J; Kaffenberger BH
    Int J Dermatol; 2018 Jun; 57(6):642-645. PubMed ID: 29450880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics and treatment options of glucagonomas: a national study from the French Group of Endocrine Tumors and ENDOCAN-RENATEN network.
    Perrier M; Brugel M; Gérard L; Goichot B; Lièvre A; Lepage C; Hautefeuille V; Do Cao C; Smith D; Thuillier P; Cros J; Cadiot G; Walter T; de Mestier L
    Eur J Endocrinol; 2023 Dec; 189(6):575-583. PubMed ID: 38039101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of necrolytic migratory erythema with somatostatin analogue in a patient diagnosed with pancreatic glucagonoma.
    Saavedra C; Lamarca A; Hubner RA
    BMJ Case Rep; 2019 Aug; 12(8):. PubMed ID: 31401568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Necrolytic migratory erythema: first symptom of a glucagonoma. A case report.
    Du Jardin P; Cools P; Van der Stighelen Y
    Acta Chir Belg; 2004 Aug; 104(4):468-70. PubMed ID: 15469167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagonoma syndrome with necrolytic migratory erythema as initial manifestation.
    Zhu WF; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2021 Dec; 20(6):598-600. PubMed ID: 34544669
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucagonoma-related necrolytic migratory erythema.
    Bosch-Amate X; Riera-Monroig J; Iranzo Fernández P
    Med Clin (Barc); 2020 Nov; 155(9):418-419. PubMed ID: 31515063
    [No Abstract]   [Full Text] [Related]  

  • 17. Migratory necrolytic erythema and glucagonoma.
    Echenique-Elizondo M; Elorza JL; De Delas JS
    Surgery; 2003 Apr; 133(4):449-50. PubMed ID: 12717367
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucagonoma Syndrome: A Rare Paraneoplastic Disorder due to Neuroendocrine Tumor of the Pancreas.
    Yusuf MA; Mehmood S; Iftikhar J; Saqib M; Siddique MZ; Imtiaz W
    J Coll Physicians Surg Pak; 2022 Aug; 32(8):S147-S149. PubMed ID: 36210677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergency pancreatic resection for glucagonoma associated with severe necrolytic migratory erythema.
    Daly DM; Thompson B; Low J; Slater J; Wood G; Kamath V; Haghighi KS
    ANZ J Surg; 2019 May; 89(5):599-602. PubMed ID: 28982222
    [No Abstract]   [Full Text] [Related]  

  • 20. Necrolytic migratory erythema: A diagnostic clue in glucagonoma syndrome.
    Moreno-Suárez F; Pulpillo-Ruiz Á; Fontillón Alberdi M
    Med Clin (Barc); 2017 Apr; 148(8):e45. PubMed ID: 27567335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.